Atara rises on plan to lay off staff
** Cell therapy developer Atara's ATRA.O shares rise 5.1% to $14.69, its highest in more than eight months ** Co to lay off 29% of staff, retaining about 15 employees ** ATRA expects to complete cuts by Jan 2026 ** Co expects ~$1.3 mln in layoff costs related to severance and other benefits ** Company says more charges may arise depending on events tied to layoffs ** Including session's move, stock up ~10% YTD (Reporting by Sahil Pandey in Bengaluru) ((Sahil.Pandey@thomsonreuters.com;))
Recent news on Atara Biotherapeutics
See all newsBrief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing
Atara Biotherapeutics Q1 revenue drops after prior-year one-time gain
Brief: Atara Biotherapeutics Q1 EPS USD -0.29
NASDAQ RESUMED AT 03:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:30 PM